- Blog: Real Estate Advisor Law BlogA Plea And/Or Request: Stop Using And/OrPosted on November 17, 2017 by Alexander S. ConnUniversity of Cincinnati Law Professor Sean Mangan does not hate many things, but ‘and/or’ has to be first on the list – along with whomever might be playing his Irish that weekend. I had the pleasure of taking multiple drafting classes with him several years ago, but I honestly never quite understood the depth of… Continue Reading
- Blog: MMM Tech Law & Business ReportMMM’s Austin Mills Discusses: “Do Token Sales Have Special Tax Considerations? And Other Blockchain Legal Implications.”Posted on November 17, 2017 by AdminSince blockchain technology and cryptocurrency are catching on quickly, laws and regulations have a long way to go to catch up. This includes tax regulations and money transmission laws. To read the full article, please click here.
- Blog: Privacy and Information Security Law BlogFTC Seeks Public Comment on Sears’ Petition to Modify Prior Order on Consumer TrackingPosted on November 16, 2017 by Hunton & Williams LLPOn November 8, 2017, Sears Holding Management Corporation requested that the FTC reopen and modify a 2009 Commission Order settling charges that Sears inadequately disclosed the scope of consumer data collected through the company’s software application.… Continue Reading
- Blog: Waller Law BlogSEC Chairman Sees ICOs as Securities OfferingsPosted on November 16, 2017 by Marc J. Adesso,Wes ScottSEC Chairman Jay Clayton spoke at the PLI Annual Institute on Securities Regulation in re: The DAO and his skepticism about ICOs being a securities offering.
- Blog: TSMP ForefrontBig data and the death of the shopping mallPosted on November 6, 2017 by How retailers can harness technology to beat e-commerce at its own game.
- Blog: Biologics BlogFed. Circ. Clarifies Law For Functional Antibody ClaimsPosted on November 2, 2017 by On Oct. 5, the Federal Circuit issued a decision in Amgen Inc. v. Sanofi (No. 2017-1480), a closely watched case involving functional antibody claims, claims that define antibodies not by their sequence or structure but by their function, such as the ability to bind a biological target. The Federal Circuit held that although written description and enablement of [...]